These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34354861)

  • 1. Inhibition of BAG3 enhances the anticancer effect of shikonin in hepatocellular carcinoma.
    Lu J; Liu SY; Zhang J; Yang GM; Gao GB; Yu NN; Li YP; Li YX; Ma ZQ; Wang Y; Lu CH
    Am J Cancer Res; 2021; 11(7):3575-3593. PubMed ID: 34354861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2.
    Liu T; Li S; Wu L; Yu Q; Li J; Feng J; Zhang J; Chen J; Zhou Y; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C
    J Hepatocell Carcinoma; 2020; 7():19-31. PubMed ID: 32110554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
    Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W; Liu J; Hou L; Chen Q; Liu Y
    Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
    Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
    Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis.
    Rihan M; Sharma SS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):145-159. PubMed ID: 37382601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
    Chen J; Xie J; Jiang Z; Wang B; Wang Y; Hu X
    Oncogene; 2011 Oct; 30(42):4297-306. PubMed ID: 21516121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PKM2 inhibitor shikonin enhances piceatannol-induced apoptosis of glyoxalase I-dependent cancer cells.
    Inoue M; Nakagawa Y; Azuma M; Akahane H; Chimori R; Mano Y; Takasawa R
    Genes Cells; 2024 Jan; 29(1):52-62. PubMed ID: 37963646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation.
    Zhang Q; Liu Q; Zheng S; Liu T; Yang L; Han X; Lu X
    J Cancer; 2021; 12(16):4830-4840. PubMed ID: 34234853
    [No Abstract]   [Full Text] [Related]  

  • 10. PKM2 Is Overexpressed in Glioma Tissues, and Its Inhibition Highly Increases Late Apoptosis in U87MG Cells With Low-density Specificity.
    Park JH; Lee JS; Oh Y; Lee JS; Park HE; Lee H; Park YS; Kyung SY; Kim HS; Yoon S
    In Vivo; 2022; 36(2):694-703. PubMed ID: 35241524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells.
    Liu J; Qu CB; Xue YX; Li Z; Wang P; Liu YH
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):105-12. PubMed ID: 26541455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
    Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
    Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.
    Li W; Zhang C; Ren A; Li T; Jin R; Li G; Gu X; Shi R; Zhao Y
    PLoS One; 2015; 10(5):e0126459. PubMed ID: 25961580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin ameliorated mice colitis by inhibiting dimerization and tetramerization of PKM2 in macrophages.
    Huang B; Wang Q; Jiang L; Lu S; Li C; Xu C; Wang C; Zhang E; Zhang X
    Front Pharmacol; 2022; 13():926945. PubMed ID: 36059938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Zhao R; Li L; Yang J; Niu Q; Wang H; Qin X; Zhu N; Shi A
    Pathol Oncol Res; 2020 Apr; 26(2):853-860. PubMed ID: 30852741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
    Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer.
    Kitayama K; Yashiro M; Morisaki T; Miki Y; Okuno T; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Hasegawa T; Sakurai K; Kubo N; Hirakawa K; Ohira M
    Cancer Sci; 2017 Dec; 108(12):2462-2469. PubMed ID: 29032577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Wang X; Zhang F; Wu XR
    Sci Rep; 2017 Apr; 7():45983. PubMed ID: 28378811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation.
    Li JH; Wang YC; Qin CD; Yao RR; Zhang R; Wang Y; Xie XY; Zhang L; Wang YH; Ren ZG
    Am J Cancer Res; 2016; 6(2):509-21. PubMed ID: 27186420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms
    Tang JC; Zhao J; Long F; Chen JY; Mu B; Jiang Z; Ren Y; Yang J
    J Cancer; 2018; 9(1):32-40. PubMed ID: 29290767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.